4.6 Article Proceedings Paper

Multimodal and Widespread Somatosensory Abnormalities in Persistent Shoulder Pain in the First 6 Months After Stroke: An Exploratory Study

Journal

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
Volume 93, Issue 11, Pages 1968-1974

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.apmr.2012.05.019

Keywords

Central nervous system sensitization; Rehabilitation; Sensory thresholds; Shoulder pain; Stroke

Ask authors/readers for more resources

Objective: To explore the role of multimodal and widespread somatosensory abnormalities in the development of persistent poststroke shoulder pain (pPSSP) in the first 6 months after stroke. Design: Prospective inception cohort study. Setting: Stroke units of 2 teaching hospitals. Participants: The data of a strict selection of patients (N=31) with a clinical diagnosis of stroke were analyzed. Interventions: Not applicable. Main Outcome Measures: The development of pPSSP within the first 6 months after stroke. Bilateral sensation and pain thresholds at 3 (t1) and 6 (t2) months, and conditioned pain modulation (CPM) at 3 months after stroke. Clinical examination within 2 weeks after stroke (t0), at t1, and at t2. Results: pPSSP (n=9) was associated with increased sensation and pain threshold ratios at the affected side (t1, t2), and with reduced cold pain tolerance at the unaffected side (t1). CPM was not different from patients without pPSSP (n=22). Notably, in patients with pPSSP reporting increased sensation on clinical examination, multiple body sites across multiple stimulus modalities were involved, and increased sensation persisted from t1 to t2. Conclusions: pPSSP in the first 6 months after stroke was associated with somatosensory loss to both innocuous and noxious stimuli (affected side). In addition, pPSSP was associated with sensitization to cold pain (unaffected side) and with widespread sensitization to multimodal innocuous stimuli (affected side). The results support the notion that central somato-sensory sensitization could play an important role in the development of pPSSP, the maintenance of pPSSP, or both.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes

Jianrong Zhang, Maarten J. IJzerman, Jasmeen Oberoi, Napin Karnchanachari, Rebecca J. Bergin, Fanny Franchini, Paige Druce, Xiaofei Wang, Jon D. Emery

Summary: This comprehensive overview examines the diagnosis and treatment times for lung cancer patients, the impact of time intervals on patient outcomes, risk factors, interventions to reduce time intervals, and methodological issues in related studies. The findings suggest that there are significant variations in diagnosis and treatment times, which often exceed the recommended guidelines. The association between time intervals and patient outcomes is inconsistent. Identified risk factors and effective interventions highlight the potential for improvement in addressing diagnostic and treatment delays.

LUNG CANCER (2022)

Article Pediatrics

Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study

Luiza R. Grazziotin, Gillian Currie, Marinka Twilt, Maarten J. Ijzerman, Michelle M. A. Kip, Hendrik Koffijberg, Susanne M. Benseler, Joost F. Swart, Sebastiaan J. Vastert, Nico M. Wulffraat, Rae S. M. Yeung, Deborah A. Marshall

Summary: This study evaluated prescription patterns of conventional and biologic disease modifying anti-rheumatic drugs (c-DMARDs and b-DMARDs) for children with juvenile idiopathic arthritis (JIA). The study found that within the first year of rheumatology care, 62% of patients were prescribed a c-DMARD and 21% were prescribed a b-DMARD. There were significant differences in prescription patterns among different subtypes of JIA, and many patients required multiple treatment lines.

PEDIATRIC RHEUMATOLOGY (2022)

Article Oncology

Disparities in quality of life, social distress and employment outcomes in Australian cancer survivors

Victoria M. White, Karolina Lisy, Andrew Ward, Eli Ristevski, Melanie Clode, Kate Webber, Jon Emery, Maarten J. Ijzerman, Nina Afshar, Jeremy Millar, Peter Gibbs, Sue Evans, Michael Jefford

Summary: The study explored the impact of socio-demographic factors, comorbidities, and information needs on the quality of life outcomes of cancer survivors. Findings showed that age, socio-economic disadvantage, comorbidities, and unmet information needs were associated with decreased quality of life scores, while higher social difficulties were related to socio-economic disadvantage, comorbidities, and unmet information needs. Comorbidities partially mediated the impact of socio-economic disadvantage on quality of life outcomes.

SUPPORTIVE CARE IN CANCER (2022)

Letter Oncology

Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial

Sarah Glewis, Marliese Alexander, Senthil Lingaratnam, Benjamin Lee, Ian Campbell, Mei Krishnasamy, Maarten IJzerman, Mussab Fagery, Sam Harris, Chloe Georgiou, Craig Underhill, Mark Warren, Robert Campbell, Jennifer Martin, Jeanne Tie, Michael Michael

ACTA ONCOLOGICA (2022)

Article Pediatrics

Factors associated with care-and health-related quality of life of caregivers of children with juvenile idiopathic arthritis

Luiza R. Grazziotin, Gillian Currie, Marinka Twilt, Maarten J. IJzerman, Michelle M. A. Kip, Hendrik Koffijberg, Gouke Bonsel, Susanne M. Benseler, Joost F. Swart, Sebastiaan J. Vastert, Nico M. Wulffraat, Rae S. M. Yeung, Wineke Armbrust, J. Merlijn van den Berg, Deborah A. Marshall

Summary: This study examines the relationship between measurements of child, caregiver, and caring context and the care-related quality of life (CRQoL) and health-related quality of life (HRQoL) of caregivers of children with juvenile idiopathic arthritis (JIA). The findings suggest that in addition to child HRQoL, socioeconomic factors such as employment and support for caregiving tasks are also associated with caregiver's quality of life.

PEDIATRIC RHEUMATOLOGY (2022)

Article Oncology

Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm

Sophie O'Haire, Koen Degeling, Fanny Franchini, Ben Tran, Stephen J. Luen, Clara Gaff, Kortnye Smith, Stephen Fox, Jayesh Desai, Maarten IJzerman

Summary: This study evaluated the clinical effectiveness of complex genomic profiling (CGP) in improving overall survival in advanced cancer patients. The results showed that patients who received treatment based on CGP results had improved survival. However, there was no significant survival benefit observed when comparing the entire CGP cohort with the cohort that did not undergo CGP analysis.

TARGETED ONCOLOGY (2022)

Article Multidisciplinary Sciences

Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer

Frederik A. van Delft, Milou Schuurbiers, Mirte Muller, Sjaak A. Burgers, Huub H. van Rossum, Maarten J. IJzerman, Hendrik Koffijberg, Michel M. van den Heuvel

Summary: This study compares nine prediction methods using longitudinal tumor biomarker data to accurately and with a low false positive rate predict non-response to immunotherapy in NSCLC patients. The study evaluated nine models of varying complexity and demonstrated the usefulness of longitudinal biomarker data in predicting treatment response.

HELIYON (2022)

Article Health Policy & Services

Do Health Technology Assessment organisations consider manufacturers' costs in relation to drug price? A study of reimbursement reports

Joost J. Enzing, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer, Werner B. F. Brouwer

Summary: Despite the high attention given to manufacturers' costs in relation to drug prices in public and academic debates, this issue does not seem to be explicitly and systematically considered in reimbursement reports for expensive drugs.

COST EFFECTIVENESS AND RESOURCE ALLOCATION (2022)

Article Health Care Sciences & Services

Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?

Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K. Mahar, Edmond M. Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A. Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran, Maarten IJzerman

Summary: The health economic outcomes of real-world treatment sequencing of androgen receptor-targeted agents (ARTA) and docetaxel (DOC) are unclear.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2023)

Review Oncology

A systematic review of methodological considerations in time to diagnosis and treatment in colorectal cancer research

Allison Drosdowsky, Karen E. Lamb, Rebecca J. Bergin, Lucy Boyd, Kristi Milley, Maarten J. IJzerman, Jon D. Emery

Summary: Research on timely diagnosis and treatment of colorectal cancer is important for improving patient outcomes. This systematic review identified methodological issues in previous research, including arbitrary categorization and lack of adjustment for confounders. Recommendations include avoiding artificial categorization, ensuring proper sequencing of key events, and using theoretical frameworks to detect and reduce bias.

CANCER EPIDEMIOLOGY (2023)

Article Rheumatology

What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey

Gillian R. Currie, Catherina G. M. Groothuis-Oudshoorn, Marinka Twilt, Michelle M. A. Kip, Maarten J. IJzerman, Susanne M. Benseler, Joost F. Swart, Sebastiaan J. Vastert, Nico M. Wulffraat, Rae Yeung, Deborah A. Marshall

Summary: The care for JIA patients has changed in the biologics era, however, biologics have important risks and are expensive. Flares after biologic withdrawal are common, but there is little clinical guidance on which patients can safely discontinue their biologics. We conducted a survey to identify the characteristics that are important to pediatric rheumatologists when considering withdrawal of biologics.

CLINICAL RHEUMATOLOGY (2023)

Article Rheumatology

Further evaluation of inflammatory and non-inflammatory aspects of pain in rheumatoid arthritis patients

Niels Jansen, Peter M. ten Klooster, Harald E. Vonkeman, Boudewijn van den Berg, Jan R. Buitenweg

Summary: This study investigated the role of Delta TSJ in understanding pain mechanisms and found that patients in the Delta TSJ >= 3 group showed significant differences in pain thresholds, pain levels, and disability. Pain catastrophizing and psychological hypervigilance did not play a significant role in these patients.

RHEUMATOLOGY ADVANCES IN PRACTICE (2023)

Article Oncology

Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care

Edwin Cuppen, Olivier Elemento, Richard Rosenquist, Svetlana Nikic, Maarten IJzerman, Isabelle Durand Zaleski, Geert Frederix, Lars-Ake Levin, Charles G. Mullighan, Reinhard Buettner, Trevor J. Pugh, Sean Grimmond, Carlos Caldas, Fabrice Andre, Ilse Custers, Elias Campo, Hans van Snellenberg, Anna Schuh, Hidewaki Nakagawa, Christof von Kalle, Torsten Haferlach, Stefan Froehling, Vaidehi Jobanputra

Summary: The combination of whole-genome and transcriptome sequencing (WGTS) is a comprehensive precision diagnostic test that is expected to transform diagnosis and treatment for cancer patients. However, there are barriers to the implementation and widespread adoption of this test, including considerations of utility in different cancer types, cost-effectiveness and affordability.

JCO PRECISION ONCOLOGY (2022)

Article Economics

Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force

William Padula, Noemi Kreif, David J. Vanness, Blythe Adamson, Juan-David Rueda, Federico Felizzi, Pall Jonsson, Maarten J. IJzerman, Atul Butte, William Crown

Summary: Advances in machine learning and artificial intelligence have great potential benefits in healthcare, including health economics and outcomes research. Machine learning can enhance these areas by analyzing big data effectively. However, a lack of transparency in how machine learning methods deliver solutions, especially in unsupervised circumstances, increases risk when using machine learning results.

VALUE IN HEALTH (2022)

Article Health Care Sciences & Services

Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis: A Formative Qualitative Study

Gillian R. Currie, Tram Pham, Marinka Twilt, Maarten J. IJzerman, Pauline M. Hull, Michelle M. A. Kip, Susanne M. Benseler, Glen S. Hazlewood, Rae S. M. Yeung, Nico M. Wulffraat, Joost F. Swart, Sebastian J. Vastert, Deborah A. Marshall

Summary: This study explores pediatric rheumatologists' approaches to treatment decision making for biologics in JIA, identifying attributes influencing initiation and tapering. Five pediatric rheumatologists participated in interviews, outlining varied tapering strategies. Fourteen attributes were selected for a BWS survey, covering patient characteristics and contextual factors. Additional research is needed to align these characteristics with patient and parent preferences.

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2022)

No Data Available